FORTISBSEFORTIS HEALTHCARE LTDHighNeutral
Announced Mon, 20 Jul · 15:18 IST

Agilus Diagnostics appoints Vijender Singh as new MD & CEO

Ceo ResignedCeo Appointed ExternalManagement Changes View source PDF

FORTIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.8%1-day move
₹952.10
prior close
₹951.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.3+1.8-0.1-0.9-0.7-1.0
Up moveDown movePending
AI summary

Agilus Diagnostics, subsidiary of Fortis Healthcare, has appointed Vijender Singh as its new Managing Director and CEO effective July 20, 2026. He replaces Dr. Anand K, who resigned after nearly six years to pursue opportunities outside the company. Singh brings over 30 years of leadership experience across diagnostics and healthcare, having previously held senior roles at Dr. Lal PathLabs, Metropolis Healthcare, Healthians and most recently Diagnum Healthcare.

Likely market impact

Smooth leadership transition at diagnostics subsidiary; brings in seasoned industry veteran with strong scaling and IPO-era track record across major diagnostic chains.